Robert A. Ortenzio
Known title: DirectorCIK: 0000918697
Associated companies
Transaction History
| CON | ▼ Sell | Other | 150,000 | $5.2M | 8/21/2026 | View on chart |
| CON | ▼ Sell | Other | 770,000 | $26.7M | 8/21/2026 | View on chart |
| CON | ▼ Sell | Other | 30,000 | $1.0M | 8/21/2026 | View on chart |
| CON | ▼ Sell | Other | 30,000 | $1.1M | 8/21/2026 | View on chart |
| CON | ▼ Sell | Other | 20,000 | $693K | 8/21/2026 | View on chart |
| CON | ▼ Sell | Open Market | 130,000 | $4.1M | 8/3/2026 | View on chart |
| CON | ▼ Sell | Open Market | 130,000 | $4.0M | 7/1/2026 | View on chart |
| CON | ▼ Sell | Open Market | 130,000 | $3.3M | 6/1/2026 | View on chart |
| CON | ▼ Sell | Open Market | 130,000 | $3.3M | 5/8/2026 | View on chart |
| CON | ▼ Sell | Gift | 100,000 | $0 | 11/25/2025 | View on chart |
| CON | ▲ Buy | Grant | 7,748 | $0 | 11/4/2025 | View on chart |
| CON | ▼ Sell | Other | 3,070,367 | $0 | 3/3/2025 | View on chart |
| CON | ▼ Sell | Other | 1,023,455 | $0 | 3/3/2025 | View on chart |
| CON | ▲ Buy | Grant | 6,496 | $0 | 11/26/2024 | View on chart |
| CON | ▲ Buy | Grant | 6,496 | $0 | 11/26/2024 | View on chart |
| CON | ▼ Sell | Other | 226,286 | $0 | 11/25/2024 | View on chart |
| CON | ▼ Sell | Other | 3,070,367 | $0 | 11/25/2024 | View on chart |
| CON | ▼ Sell | Other | 226,286 | $0 | 11/25/2024 | View on chart |
| CON | ▼ Sell | Other | 5,513,054 | $0 | 11/25/2024 | View on chart |
| CON | ▼ Sell | Other | 1,032,115 | $0 | 11/25/2024 | View on chart |
| CON | ▼ Sell | Other | 226,286 | $0 | 11/25/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CON reaches 52‑week high amid health sector activity
Concentra Group Holdings rose to a 52‑week high of $36.83. The move comes as other health‑care companies reported developments, such as Teladoc adding AI‑driven care tools and Encompass Health opening a new rehabilitation hospital in Maine. The stock’s momentum is reflected in an RSI above 60 and recent support around $22.25.
CON reaches 52‑week high amid health sector activity. Concentra Group Holdings rose to a 52‑week high of $36.83. The move comes as other health‑care companies reported developments, such as Teladoc adding AI‑driven care tools and Encompass Health opening a new rehabilitation hospital in Maine. The stock’s momentum is reflected in an RSI above 60 and recent support around $22.25.